Science
FDA Approves Lembaz, First Drug Shown to Extend Survival in Infantile-Onset Niemann-Pick Disease
Lembaz is the first treatment shown to extend survival in infantile-onset Niemann-Pick disease type C. In FDA-reviewed data, treated patients…